Marine Drugs · 2010 · 102 citations · 21 references
Life SciencesMedicinal ChemistryPharmacologyApoptosisCancer PharmacologyMitochondrial BiologyApoptosis ModulationApoptosis PharmacologyFungal Secondary MetabolitesMarine Drug DiscoveryAnticancer ActivityAnticancer Mechanism Of ActionChemical Structure-activity RelationshipsEndophytic Fungal MetabolitesEndophytic FungiMarine Secondary MetabolitesMarine-derived Anticancer CompoundsSecondary Metabolites
In this article, we report anticancer activity of 14 anthracenedione derivatives separated from the secondary metabolites of the mangrove endophytic fungi Halorosellinia sp. (No. 1403) and Guignardia sp. (No. 4382). Some of them inhibited potently the growth of KB and KBv200 cells, among which compound 6 displayed strong cytotoxicity with IC(50) values of 3.17 and 3.21 microM to KB and KBv200 cells, respectively. Furthermore, we demonstrate that the mechanism involved in the apoptosis induced by compound 6 is probably related to mitochondrial dysfunction. Additionally, the structure-activity relationships of these compounds are discussed.
21
Marine natural products as anticancer drugs
Thomas L. Simmons, Eric H. Andrianasolo, Kerry L. McPhail et al. · Molecular Cancer Therapeutics · 2005 · 592 citations
Mark J. Smyth, Erika Krasovskis, Vivien R. Sutton et al. · Proceedings of the National Academy of Sciences · 1998 · 361 citations
Medicine, Oncology, Pharmacology +17